Copy Link Print Information

Spevatamig

(Synonyms: PT-886)
Avis client

Based on 1 Customer Validation

HY-P991027 is an CD47/CLDN18-targeting (H-γ1_L-κ)_(H-γ1_L-κ) type bispecific antibody.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: ≥99.0%
  • CAS No.: 2928515-36-8
  • Masse moléculaire:145.181 kDa
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Spevatamig
  • Experimental Validation Results for Spevatamig
  • Experimental Validation Results for Spevatamig
  • Experimental Validation Results for Spevatamig
  • Spevatamig Chemical Structure
    Spevatamig Chemical Structure
CAS No.: 2928515-36-8
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Spevatamig Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa

  • 1/16

    Immobilized CD47 Protein, Human (HEK293, His, HY-P7336) can bind Spevatamig. The EC50 for this effect is 158 ng/mL.

  • 1/16

    Immobilized Claudin-18/CLDN18.2 Protein-VLP, Human (HEK293, HY-P78368) can bind Spevatamig. The EC50 for this effect is 15.05 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 Juakat cells with Spevatamig (HY-P991027, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Spevatamig Chemical Structure
    1/16
  • Spevatamig
  • Immobilized CD47 Protein, Human (HEK293, His, HY-P7336) can bind Spevatamig. The EC50 for this effect is 158 ng/mL.
  • Immobilized Claudin-18/CLDN18.2 Protein-VLP, Human (HEK293, HY-P78368) can bind Spevatamig. The EC50 for this effect is 15.05 ng/mL.
  • Flow cytometric analysis of 1X106 Juakat cells with Spevatamig (HY-P991027, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • IgG1-kappa